SOX9 and acute myeloid leukemia: IPA analysis proposed a model of altered adipogenic differentiation in AML-MSCs attributable to lower expression of two key regulatory genes, SOX9 (SRY-related high mobility group-Box gene 9) and EGR2 (early growth response gene 2; Fig. 3b).